Neurology at Biology Products
Neurology at Biology Technology
Neurology at Medicine News
Helping the neurology of kidney failure
Antioxidants may be able to treat the neurological problems that are common in kidney failure.More than 300,000 people in the US suffer from kidney failure, which is usually caused by diabetes, high blood pressure or infection. Kidney failure often leads to neurological complications like fatigue, apathy, emotional instability and even convulsions and coma. // Researchers at the Uni...
Neurology behind Drinking in Teenagers
For as long as one can remember concerned adults have tried to limit teenage alcohol consumption. Public health experts often warn that teenage drinkers //show increased risks of involvement in car accidents, and fights. But while early drinking was blamed for time away from homework acquiring social skills, and other related tasks of growing up mounting research has shown that alcohol...
Neurology at Medicine Products
ChartLogic Neurology Electronic Medical Office
Description:ChartLogic™ is a revolutionary Electronic Medical Office (EMO) truly built for the
Neurology specialist and customized for the unique needs of your practice. The ChartLogic™ EMO incorporates the benefits of an electronic record system (EMR, EHR, and EPR), and then takes your entire practice to a new level of efficiency and performance. In addition to retrieving and storing your charts...
Company:ChartLogic
Clinical Neurology 2007
Description:Topics included in the Clinical
Neurology 2007 are: evaluation of weakness, neuropathy, myasthenia gravis, demyelinating disease including MS and Guillain-Barre, carpal tunnel, cerebellar disorders, movement disorders (tics, Tourette, dystonia..), tremors, Parkinsons, cerebral palsy, ALS, seizures, strokes, headaches, coma, cervical spine problems, low back pain, radiculopathy, sciatica, myofacia...
Company:Mobipocket.com
The Massachusetts General Hospital Handbook of Neurology
Description:
Neurology, neurosurgery, and internal medicine residents and practitioners will find this mobile solution an essential reference for their day-to-day practice....
Company:Skyscape, Inc.
Merritt's Neurology Handbook
Description:The perfect solution for quick, easy reference on the wards, on rounds, in the office, and at the bedside. See vital information on specific signs and symptoms, diagnostic tests, and the gamut of neurologic conditions....
Company:Skyscape, Inc.
PocketMedicine/IM-Neurology
Description:PocketMedicine/IM-
Neurology is an all-original guide prepared specifically for use on handheld devices. Derived from "PocketMedicine/Internal Medicine", it will prove invaluable not only to those training in the field, but to those non-neurologists who are frequently the first to encounter these problems....
Company:PocketMedicine.com, Inc.
More>>
Neurology at Medicine Technology
Medivation Announces Presentation of New Subset Analyses From
Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of
Neurology Annual Meeting
Company Conference Call Scheduled for Friday, May 4, at 9:00 a.m.Eastern Time to Discuss Data SAN FRANCISCO, May 03, 2007 /PRNewswire-FirstCall/ --Medivation, Inc. today announced that new data from the mild andmoderate subgroups of Alzheimer's disease patients in the Company'ssix-month Phase 2 efficacy study of Dimebon showed that bothsubgroups were improved compared with placebo-treated...
Acorda Therapeutics Presents Data from its Phase 3 Study of
Fampridine-SR in Multiple Sclerosis at the American Academy of
Neurology Meeting
BOSTON--(BUSINESS WIRE)--May 2, 2007 - Acorda Therapeutics, Inc.(R)(Nasdaq: ACOR) today presented data from a Phase 3 clinical trialof Fampridine-SR in people with multiple sclerosis (MS) at theAmerican Academy of
Neurology meeting. Andrew Goodman, M.D.,Director of the Multiple Sclerosis Center at the University ofRochester, presented top-line results on walking ability, legstrength, spasti...
Studies Presented at Neurology Conference Highlight Early Efficacy,
Long-Term Tolerability, and High Patient Satisfaction with
Betaseron
BOSTON, May 03, 2007 /PRNewswire/ -- Bayer HealthCarePharmaceuticals announced today the results of three clinicalstudies with Betaseron(R) (interferon beta-1b), presented this weekat the American Academy of
Neurology's (AAN) 59th Annual Meeting,demonstrating early efficacy, long-term tolerability, and highpatient satisfaction with treatment in patients with relapsingforms of multiple sc...
Data Presented at the American Academy of Neurology's Annual
Meeting Provide Update on Utilization and Safety of Tysabri in
Patients with Multiple Sclerosis
BOSTON--(BUSINESS WIRE)--May 3, 2007 - Biogen Idec (NASDAQ: BIIB)and Elan Corporation, plc (NYSE: ELN) announced today that new datafrom the TOUCH Prescribing Program(TM) and TYGRIS safety studyconfirm the safety profile from previous clinical studies ofTYSABRI(R) (natalizumab). Also presented at the 59th annual meetingof the American Academy of
Neurology in Boston, MA were extensionstudy d...
Accera, Inc. Announces Results of Phase II Study in Alzheimer's
Disease at American Academy of Neurology Meeting
BROOMFIELD, Colo., May 01, 2007 /PRNewswire/ -- Accera Inc. ispresenting topline data today from its Phase IIb study of its leadcompound AC-1202 in Alzheimer's disease (AD) at the AmericanAcademy of
Neurology (AAN) 59th Annual Meeting in Boston. Judged bythe AAN to be in the top five percent of the program, the data willalso be featured in the Scientific Highlights Plenary Session. <p...
More>>
Neurology at Medicine Dictionary
Neurology
<A href="http:/
/
www.medterms.com/
script/
main/
art.as...